12 Health Care Stocks Moving In Thursday's Pre-Market Session

Bluejay Diagnostics, Inc. +2.06% Post
Cingulate, Inc. -1.26% Post
CRINETICS PHARMACEUTICALS, INC. -0.08% Post
CytoSorbents Corporation -10.61% Post
Enveric Biosciences, Inc. -5.58% Post

Bluejay Diagnostics, Inc.

BJDX

1.98

1.98

+2.06%

0.00% Post

Cingulate, Inc.

CING

6.28

6.42

-1.26%

+2.23% Post

CRINETICS PHARMACEUTICALS, INC.

CRNX

36.31

36.31

-0.08%

0.00% Post

CytoSorbents Corporation

CTSO

0.60

0.60

-10.61%

0.00% Post

Enveric Biosciences, Inc.

ENVB

1.86

1.86

-5.58%

0.00% Post

Gainers

  • Cingulate (NASDAQ:CING) stock moved upwards by 188.5% to $11.51 during Thursday's pre-market session. The market value of their outstanding shares is at $10.7 million.
  • SenesTech (NASDAQ:SNES) shares rose 82.02% to $1.57. The company's market cap stands at $1.1 million.
  • Palisade Bio (NASDAQ:PALI) shares moved upwards by 55.83% to $0.94. The market value of their outstanding shares is at $8.6 million.
  • Milestone Scientific (AMEX:MLSS) stock moved upwards by 26.72% to $0.8. The company's market cap stands at $60.5 million.
  • Enveric Biosciences (NASDAQ:ENVB) stock increased by 26.67% to $1.65. The market value of their outstanding shares is at $3.8 million.
  • Telesis Bio (NASDAQ:TBIO) stock rose 23.93% to $0.48. The market value of their outstanding shares is at $14.4 million.

Losers

  • Bluejay Diagnostics (NASDAQ:BJDX) stock fell 34.5% to $1.15 during Thursday's pre-market session. The company's market cap stands at $1.4 million.
  • CytoSorbents (NASDAQ:CTSO) shares fell 32.52% to $1.1. The market value of their outstanding shares is at $57.3 million.
  • First Wave BioPharma (NASDAQ:FWBI) stock declined by 15.74% to $4.66. The market value of their outstanding shares is at $3.1 million.
  • NKGen Biotech (NASDAQ:NKGN) stock declined by 12.05% to $2.92. The company's market cap stands at $63.9 million.
  • Intensity Therapeutics (NASDAQ:INTS) shares declined by 10.59% to $6.0. The company's market cap stands at $82.2 million.
  • Crinetics Pharmaceuticals (NASDAQ:CRNX) shares decreased by 9.98% to $32.75. The company's market cap stands at $2.1 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.